Published in
Elsevier, European Journal of Cancer, (116), p. 148-157, 2019
DOI: 10.1016/j.ejca.2019.05.020
Links
Tools
Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma
Journal article published in 2019 by
Shahneen Sandhu 
,
Susana Puig ,
Piotr Rutkowski ,
Dirk Schadendorf ,
Alfonsus J.-M. van den Eertwegh,
Sandrine Marreaud,
Alexander C. van Akkooi,
Stefan Suciu,
Caroline Robert,
Alexander Mm M. Eggermont,
Christian U. Blank,
Mario Mandala,
Georgina V. Long ,
Victoria G. Atkinson,
James Larkin
and other authors.
,
Susana Puig ,
Piotr Rutkowski ,
Dirk Schadendorf ,
Alfonsus J.-M. van den Eertwegh,
Sandrine Marreaud,
Alexander C. van Akkooi,
Stefan Suciu,
Caroline Robert,
Alexander Mm M. Eggermont,
Christian U. Blank,
Mario Mandala,
Georgina V. Long ,
Victoria G. Atkinson,
James Larkin
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 